Presbyterian Healthcare Expands GW RhythmX AI Platform to 200 Clinicians
Presbyterian Healthcare Services has expanded its use of the GW RhythmX AI Precision Care Platform to 200 primary care clinicians, announced in a press release. The deployment marks the first full-system rollout of the precision care AI platform within the health system.
The expansion follows a pilot program that helped clinicians identify and review more than 200 health conditions across 10,000 patient encounters. The platform generated over 17,000 personalized treatment responses and reduced hours of manual data review by consolidating key patient information within its Epic electronic health record integration.
Clinicians reported faster access to relevant clinical data, payer criteria, and social determinants of health, allowing more time for patient interaction. According to Presbyterian Healthcare Services, the system supports efforts to improve care quality and efficiency while addressing the growing complexity of clinical practice.
The platform, developed by GW RhythmX, combines AI-driven clinical insights with workflow integration to assist healthcare providers in delivering personalized care at scale. The organization plans to continue leveraging the technology to enhance care delivery across its network.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Genzeon Wins UiPath Healthcare and Life Sciences Partner Award
PhyPal Relaunches Patient Engagement Platform With Conversational AI
Zivian Health Launches Elevate AI Chart Review Tool
Gemini Health Partners Launches AI Revenue Cycle Advisory Service
Assort Health Expands AI Agents to More Than 1,300 Primary Care Providers
Daily AI Brief: the AI news that matters, in your inbox.